|
A more recent version of this article appeared on February 1, 2004
Papers In Press, published online ahead of print November 1, 2003
J. Lipid Res., doi:10.1194/jlr.M300353-JLR200
Submitted on August 18, 2003
Revised on October 22, 2003
Accepted on October 23, 2003
Molecular characterization of rabbit scavenger receptor class B type I and II: Portal to central vein gradient of expression in the liver
Andreas Ritsch, Ivan Tancevski, Wilfried Schgoer, Christa Pfeifhofer, Roland Gander, Philipp Eller, Bernhard Foeger, Ursula Stanzl, and Josef R. Patsch
Department of Medicine, University of Innsbruck, Innsbruck, Innsbruck A-6020
Corresponding Author: andreas.ritsch{at}uibk.ac.at
To further elucidate the role of scavenger receptor class B type I (SR-BI) in reverse cholesterol transport and in atherogenesis, we performed studies in the rabbit, an animal model displaying a lipoprotein profile similar to that of humans, expressing cholesteryl ester transfer protein in plasma and having been demonstrated to be susceptible to atherosclerosis. In this report we describe, for the first time, isolation and characterization of rabbit cDNA fragments encoding SR-BI and SR-BII, respectively. Development of an isoform specific Taqman Real Time PCR system and generation of isoform specific polyclonal antibodies allowed us to measure SR-BI/II expression in various rabbit organs on mRNA and protein levels, respectively. We found highest expression of SR-BI in adrenal gland, liver and proximal intestine, and, to a less extent, expression in appendix and spleen. Immunohistochemical staining of frozen sections showed SR-BI expression in the cortex but not the medulla of adrenals. An increasing portal to central vein gradient of expression was found within the hepatic lobule. Identification and characterization of SR-BI expression in the rabbit affords as shown in this report a powerful tool to elucidate the role of SR-BI in cholesterol homeostasis and atherogenesis in humans.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Tancevski, A. Wehinger, E. Demetz, J. Hoefer, P. Eller, E. Huber, U. Stanzl, K. Duwensee, K. Auer, W. Schgoer, et al.
The thyromimetic T-0681 protects from atherosclerosis
J. Lipid Res.,
May 1, 2009;
50(5):
938 - 944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Parathath, Y. F. Darlington, M. de la Llera Moya, D. Drazul-Schrader, D. L. Williams, M. C. Phillips, G. H. Rothblat, and M. A. Connelly
Effects of amino acid substitutions at glycine 420 on SR-BI cholesterol transport function
J. Lipid Res.,
June 1, 2007;
48(6):
1386 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tancevski, A. Wehinger, W. Schgoer, P. Eller, S. Cuzzocrea, B. Foeger, J. R. Patsch, and A. Ritsch
Aspirin regulates expression and function of scavenger receptor-BI in macrophages: studies in primary human macrophages and in mice
FASEB J,
July 1, 2006;
20(9):
1328 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Hirano, C. Ikegami, K.-i. Tsujii, Z. Zhang, F. Matsuura, Y. Nakagawa-Toyama, M. Koseki, D. Masuda, T. Maruyama, I. Shimomura, et al.
Probucol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly Through a Species-Specific Mechanism
Arterioscler Thromb Vasc Biol,
November 1, 2005;
25(11):
2422 - 2427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Parathath, D. Sahoo, Y. F. Darlington, Y. Peng, H. L. Collins, G. H. Rothblat, D. L. Williams, and M. A. Connelly
Glycine 420 Near the C-terminal Transmembrane Domain of SR-BI Is Critical for Proper Delivery and Metabolism of High Density Lipoprotein Cholesteryl Ester
J. Biol. Chem.,
June 11, 2004;
279(24):
24976 - 24985.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|